The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Transforming growth factor–β in tissue fibrosis
Open accessAbstract
TGF-β is extensively implicated in the pathogenesis of fibrosis. In fibrotic lesions, spatially restricted generation of bioactive TGF-β from latent stores requires the cooperation of proteases, integrins, and specialized extracellular matrix molecules. Although fibroblasts are major targets of TGF-β, some fibrogenic actions may reflect activation of other cell types, including macrophages, epithelial cells, and vascular cells. TGF-β–driven fibrosis is mediated through Smad-dependent or non-Smad pathways and is modulated by coreceptors and by interacting networks. This review discusses the role of TGF-β in fibrosis, highlighting mechanisms of TGF-β activation and signaling, the cellular targets of TGF-β actions, and the challenges of therapeutic translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–208 of 208
Muñoz‐Félix, J. M., Perretta‐Tejedor, N., Eleno, N., López-Novoa, J. M., & Martínez‐Salgado, C. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.02.017 · Cited by 32
Wermuth, P. J., Carney, K. R., Mendoza, F. A., Piera-Velázquez, S., & Jiménez, S. A. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.23 · Cited by 32
Distribution of TGF‐β isoforms and signaling intermediates in corneal fibrotic wound repair
Huh, M., Kim, Y., Park, J., Bae, S., Kim, M., Chang, Y., Kim, S., Lee, S., Lee, Y., Jin, E., et al. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22277 · Cited by 30
TAK1 Is Required for Dermal Wound Healing and Homeostasis
Guo, F., Hutchenreuther, J., Carter, D. E., & Leask, A. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.28 · Cited by 28
Inhibition of type III TGF-β receptor aggravates lung fibrotic process
Ahn, J., Park, S., Yun, Y., & Song, J. (2010) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2010.01.006 · Cited by 24
Pericacho, M., Velasco, S., Prieto, M., Llano, E., López-Novoa, J. M., & Rodríguez‐Barbero, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054687 · Cited by 23
Rodriguez, A. C., Friman, T., Kowanetz, M., van Wieringen, T., Gustafsson, R., & Sundberg, C. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.054 · Cited by 23
Thrombospondin-1 is not the major activator of TGF-β1 in thrombopoietin-induced myelofibrosis
Evrard, S., Bluteau, O., Tulliez, M., Rameau, P., Gonin, P., Zetterberg, E., Palmblad, J. E. W., Bonnefoy, A., Villeval, J., Vainchenker, W., et al. (2010) · Blood · doi:10.1182/blood-2010-07-294447 · Cited by 19
Cited by
Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229
Self-citationPathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Moss, B. J., Ryter, S. W., & Rosas, I. O. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-030240 · Cited by 821
SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis
Wendisch, D., Dietrich, O., Mari, T., von Stillfried, S., Ibarra, I. L., Mittermaier, M., Mache, C., Chua, R. L., Knoll, R., Timm, S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.11.033 · Cited by 528
Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer
Buechler, M. B., Fu, W., & Turley, S. J. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.021 · Cited by 494
Transforming growth factor-β in myocardial disease
Frangogiannis, N. G. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00646-w · Cited by 344
Self-citation
Metadata
- Authors
- Frangogiannis, N. G.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2020-02-20
- Volume
- 217
- Issue
- 3
- Pages
- e20190103-e20190103
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W3007757041
- Cited by
- 1,278
- References
- 208
- FWCI
- 19.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.